NCCAA Certification Practice Exam

The condition associated with an altered response to neuromuscular blockers when using echothiopate is chronic glaucoma. Echothiopate is an anticholinesterase agent used primarily for the treatment of glaucoma, and its effects can extend beyond the eye, particularly in the neuromuscular system.

In patients with chronic glaucoma, the use of echothiopate can lead to prolonged neuromuscular blockade because the drug inhibits the breakdown of acetylcholine at the neuromuscular junction. This mechanism can significantly amplify the effects of neuromuscular blockers, resulting in potential complications such as prolonged muscle weakness or paralysis during anesthesia.

This heightened sensitivity in individuals with chronic glaucoma is due to the underlying pathophysiology of the condition and the pharmacological action of echothiopate. Since the other conditions listed do not have a similar direct relationship with neuromuscular blockades in the context of echothiopate administration, they do not create the same level of concern related to altered neuromuscular responses.